Medical AI

With Luna Federici as CEO, PicnicAI isn't just changing leaders; it's accelerating its mission to industrialize AI for health research and patient care.

Ottawa's new $100M investment in health data infrastructure promises to accelerate research and improve care, but navigating privacy hurdles will be critical.

Skye Salud's move into primary care testing in Mexico is more than a trial; it's a blueprint for deploying resilient, evidence-based AI in regulated industries.

Spotlight Medical's myStage Dx secures tough IVDR CE mark, using AI on standard lab slides to help doctors pinpoint which patients can safely avoid chemo.

Polish startup MY OVU wins a coveted spot at CES 2027. Its intelligent thermometer signals a new era for women's health and European tech innovation.

GuideAI Health's new AI software, which scans for peripheral vascular disease, promises to slash diagnosis times and prevent amputations for millions.

Masimo's FDA-cleared AI monitor for opioid risk does more than track vitals; it predicts danger, pushing healthcare from reactive alarms to proactive intervention.

A startup just raised $5M for an AI that teaches cells to be better factories. It's a glimpse into a future of cheaper, faster advanced medicines for all.

Genialis's new BioBridge platform uses AI to de-risk the $137B flow of oncology drugs from China to the West, a critical test of resilience.

A California clinic known for ketamine bets on the booming NAD+ IV market. As wellness clinics expand, experts question if the science supports the high price tag.

Digital health innovator Light AI has secured C$5M to navigate the regulatory maze. Can its AI platform truly revolutionize diagnostics from our pockets?

uniQure's early trial data for AMT-260 shows promise in reducing severe seizures, but experts urge cautious optimism on the long road to a cure.

For decades, insomnia treatment meant risky sedatives. Now, a new class of drugs is revolutionizing sleep science, promising safer rest for millions.

A new alliance aims to get an FDA-cleared device for a painful chemo side effect into patients' hands, tackling the hidden barriers of healthcare logistics.

New real-time imaging gives surgeons a 3D molecular map of cancer in the OR, poised to end the emotional and physical toll of reoperations for many.

For years, CIDP patients faced limited options. Now, a wave of targeted therapies promises to transform treatment, sparking a multi-billion dollar market boom.

A silent health crisis affecting a billion women is becoming a major economic focus. One firm's move to train a new workforce signals a paradigm shift.

Nuwellis bets on educating hundreds of physicians on its Aquadex system, a high-stakes strategy to combat fluid overload and secure its place in medicine.

A new grant from The Michael J. Fox Foundation highlights a radical approach to Parkinson's: targeting astrocytes to restore balance and halt neurodegeneration.